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 Hox genes are a subgroup of the large family of homeobox containing genes, known to 
pattern anterior/posterior and proximal/distal axes during embryonic development.  More 
recently Hox gene research has focused on the role of these genes during carcinogenesis.  We 
studied the pattern of Hox gene expression in a human colorectal adenocarcinoma cell line, 
HT29, in response to treatment with a histone deacetylase inhibitor, sodium butyrate.  Sodium 
butyrate treatment has been previously described to differentiate HT29 cells.  The cells acquire 
differentiated characteristics after a seven-day treatment period with 5 mM sodium 
butyrate.  These features include increased microvilli concentrations, tight junctions, and the 
formation of apical and basolateral domains.  Our research aimed to study the role of Hox genes 
in colorectal cancer by analyzing their expression in both proliferative and growth-inhibited 
HT29 cells.   The first phase of our research was to determine the pattern of expression for all 39 
characterized human Hox genes using RT-PCR in order to select genes of interest that are 
differentially between proliferating and differentiated HT29 cells.  The second was to verify the 
differential expression of these genes with qRT-PCR and Western blot.  It was observed that 
most genes of cluster D were expressed in untreated but not treated HT29 cells.  More 
specifically, D8 and D9 were the only two genes of this cluster with a differential pattern of 
expression than the other genes of their paralog groups. We hypothesized that D8 and D9 are 
  
responsible for maintaining the proliferative, undifferentiated state of the HT29 cells.  Using 
qRT-PCR analysis, D8 was shown to be up-regulated in untreated HT29 cells in comparison to 
treated HT29 when normalized to housekeeping genes.  However, D9 was shown to be down-
regulated in untreated HT29 in comparison to treated HT29 when normalized to housekeeping 
genes.  The Western blot for Hox D9 reflected the findings of RT-PCR but not qRT-
PCR.  Protein expression was present in untreated HT29 cell lysates, but not the sodium butyrate 
treated lysates.  D8 showed no protein expression in either untreated or treated cell lysates. The 
effects of sodium butyrate treatment on HT29 cell proliferation and differentiation was assessed 
using growth curves and ultrastructural analysis by transmission electron microscopy. It was 
observed that when cells are seeded at a low density (9.6 x 104) and recorded for seven days, 
sodium butyrate treatment effectively inhibited cellular proliferation.  Electron micrographs 
showed that NaBT treated HT29 cells exhibited potential apical domains, increased 
concentrations of microvilli, tight junctions and approximately double the number of 
desmosomes at intercellular junctions.  In addition, some of the treated cells exhibited the 
formation of mucin granules, specific to the phenotype of epithelial goblet cells. 
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 Chapter 1: Introduction 
 
 Each year in the United States, there are over 100,000 new diagnosed cases of colorectal 
cancer; more than 50,000 of these cases result in death.  The majority of these diagnosed 
colorectal cancers begin as adenocarcinomas.  Among the advancing treatment options, targeted 
cancer therapies have been heavily studied due to their level of effectiveness and less harmful 
nature. [CDC 2012]  This targeted cancer therapy, or gene therapy, focuses on ways to 
manipulate genes that are responsible for promoting tumor growth and metastases.  The 
heightened interest in and need for viable targets for gene therapy influenced the direction of this 
project. 
 
1.1.1: Hox Genes: Homeobox-containing Genes 
 Hox genes are a subgroup of the large family of homeobox-containing genes, originally 
discovered in the common fruit fly, Drosophila melanogaster [Grier 2005, Shah 2010].  In 
Drosophila, these genes control the body plan during embryonic development.  Due to this 
property, they were named homeotic genes [Freschi 2005].  The developmental roles of these 
genes were determined by mutations that arose as phenotypical changes: i.e. legs replaced by 
antennae [Shah 2010].   
 The homeobox is a sequence of DNA approximately 180 base pairs in length, which 
encodes a protein domain known as the homeodomain.  This domain, located within exon 2, 
encodes a DNA binding motif and is relatively well conserved among Hox genes.  Hox proteins 
can function to directly drive transcription of targeted genes or interact with members of the 3-
amino acid loop extension family of cofactors (TALE). [Shah 2010] 
 While Hox genes have been well described for their role in embryonic development, it is 
now clear that they are also important 
addition, there has been a suggested potential role of homeodomain
neoplasia of cancer lesions.  These 
within the genes, in part causing the onset of oncogenesis
the HOMC/Hox family while others are members of the other characterized homeotic gene 
families.  [Chariot 1996]   
 
1.1.2: Hox Genes: Evolutionary History
 Homeobox-containing genes
described as evolutionarily conserved transcription factors that function to pattern the 
development of embryos and participate in 
tissue differentiation.   
Humans have over 200 homeobox 
genes dispersed throughout the genome. 
[Abate-Shen 2002, Freschi 2005]  However, 
only 39 of these 200+ genes belong to the 
gene family.  Mammalian Hox genes are 
organized into four clusters—A, B, C and D
located on different chromosomes (7, 17, 12 
and 2, respectively).   The number of clusters 
varies amongst organisms and the complexity of the
number of clusters/complexity corollary 
2 
in post-embryonic maintenance of the organism.  In 
-containing proteins in 
roles are attributed to viral integrations and translocations 
.  Some of these genes are members of 
 
 are found in all bilateral organisms.  They are commonly 
Hox 
—
ir anatomy. [Shah 2010]  Although 
does not necessarily dictate that more complex 
Figure 1. Hox gene family diagram, showing the 
clusters on their respective chromosomes depicting 
paralogs in their spatial colinear alignment.  The colors 
represent dominance, purple being most dominant an
yellow being the least. Reprinted by permission 
Macmillan Publishers Ltd: Nature Reviews Cancer
(Shah 2010), copyright 2010. 
the 
d 
from 
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organisms have a greater number of clusters.  Each of these four complexes of clusters spans 
approximately 200 kilobases and contains between 9 to 11 genes each [Zeltser1996].  These four 
complexes arose by two rounds of genome duplication.  Therefore, Hox genes that are located at 
the same position in different clusters (thus separate chromosomes) are called paralogs.  These 
paralogs are a division of the homologs, or genes sharing a common origin.  Due to common 
ancestry, the paralogous genes may have similar, overlapping functions or a new function due to 
lack of selective pressure on one or more copies of the duplicated gene.  That is to say that genes 
on different chromosomes that are located in the same position have more similar patterns of 
expression and share more sequence similarities than genes located along the same chromosome 
in varying positions [Greer 2000].  In vertebrates, there are 13 paralog groups.  These paralogs 
are numbered along a chromosomal axis, with 1 being the most 3’ and 13 being the most 5’.  The 
expression of these genes along the anterior-posterior body axis corresponds to their position 
along the 3’ to 5’ cluster.  The 3’ genes are expressed more anteriorly than those of the 5’ region. 
[Shah 2010]  This property is described as spatiotemporal colinearity [Grier 2005]. 
Interestingly, between humans and mice, most paralogous subsets have been maintained 
in both organisms [Zeltser 1996].  A significant number of murine studies have been conducted 
in order to determine the roles of these Hox genes in vivo.  For example, to determine 
overlapping function of paralogous genes, a group of researchers [Greer 2000] study paralog 
group 3 to determine the biological function of these related genes.  They discovered that genes 
Hoxa3, b3 and d3 in mice share nearly identical patterns of expression and approximately 50% 
similarity of protein-coding sequences.  In contrast, they determined that knocking out either one 
of Hoxa3 or d3 resulted in no overlapping phenotypes.  These data suggest that the genes may 
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have acquired different functions through interaction with different partner proteins. [Greer 
2000] 
 
1.2.1: Developmental Roles: Hox Genes 
 Hox genes serve as a template of development along the anterior-posterior and proximal-
distal body axes of bilateral organisms.  During embryogenesis, Hox gene expression pattern 
reflects their roles in segmentation, location along the chromosome and within a cluster, and the 
fate of varying tissue and cell types [Abate-Shen 2002].  In balanced expression of these genes, 
Hox genes also drive the development of organs [Shah 2010].   
 
1.2.2: Developmental Roles: Hox Paralogs 8 and 9 
  Hox paralog groups 8 and 9 contain seven genes: A9, B8, B9, C8, C9, D8 and D9.  These 
genes are expressed more posteriorly, with their locations closer to the 5’ end of the chromosome 
[Figure 1].  For example, in developing mice, Hox genes a9, b9 and d9 control the development 
of mammary glands and ducts in response to pregnancy. [Chen 1999]  In the development of 
chick limbs, it has also been observed that 5’-most genes of Hoxa and Hoxd clusters are 
expressed in the wrist, ankles and digits.  The expression of these genes were localized to 
developmental regions of the forelimb and proximal limb, including the humerus, femur, 
fibula/tibula or radius/ulna. [Grier 2005] 
 
1.3.1: Post-embryonic and Oncogenic Roles: Hox Genes 
 While Hox genes have been extensively studied during embryonic development, they are 
also expressed in various adult tissues [Boudreau 1997, Freschi 2005, Grier 2005].  The genes 
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expressed during embryonic development are believed to regulate cellular proliferation, 
migration and differentiation; however in the adult, it seems they play a role in the maintenance 
of the differentiated state of the tissue.   
Hox gene mis-expression has recently been linked to cell growth and carcinogenesis.  In 
tissues expressing up-regulated Hox genes, the cells tend to be undifferentiated and growing at a 
more rapid rate. [Abate-Shen 2002]  In cancerous tissues, some Hox genes normally possess 
tumor suppressive characteristics; instead the genes are silenced and thus down-regulated.  
Additionally, some tissues express Hox genes in aberrant patterns that similarly result in 
oncogenic effects.   This deregulation of Hox genes causes many different types of cellular 
changes in which cells escape the normal growth pathways.  Examples of cells escaping the 
normal pathways include: leukemias in which fusion-protein mediated over-expression of Hox 
genes promotes clonal expansion; neuroblastomas in which expression of a single Hox gene 
promotes differentiation and prevents tumorigenesis; and abnormal Hox expression drives 
overexpression through apoptotic escape, altering cell receptor signaling, epithelial mesenchymal 
transition, or tumor cell invasion.  [Shah 2010]   
For example, Hox B13 normally functions as a tumor suppressor gene that is necessary 
for the development of organisms.  However, when B13 is expressed in an aberrant pattern, 
aggressive disease and tumorigenesis is observed.  [Shah 2010]  In addition to B13, there are 
several other genes that have some well-studied roles in oncogenesis.  Loss of expression 
through promoter methylation of Hox A5 is found in more than 60% of breast cancers that arise 
with the loss of p53 functionality, cell cycle regulating “check-point”.  In contrast, A1 is found to 
be up-regulated in neoplastic breast tissues.  Similarly, B7 is overexpressed in breast and ovarian 
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cancers, as well as melanomas.  A7 is highly activated in differentiated ovarian tissues of the 
epithelium. [Abate-Shen 2002, Samuel 2005, Shah 2010] 
 
1.3.2: Post-embryonic and Oncogenic Roles: Hox Paralogs 8 and 9 
In addition to the regulatory abilities of these genes in various pathways, the genes of 
paralogs 8 and 9 are also highly active in oncogenesis.  For example, Hox genes closer to the 5’ 
end of the chromosome, more specifically those of clusters A and D, have been linked to 
overexpression in primary carcinomas of the lung. [Shah 2010] 
  Hox A9, in both human and murine studies, has been linked to hematopoietic 
stem cell renewal and is thought to be a major component in myeloid leukemias, acute 
lymphoblastic and acute myeloid leukemias.  Hox A9 has also been linked to hematopoietic stem 
cell expansion. [Thornsteindottir 2002] A9 overexpression is also correlated to a decrease in 
early B-cell development.  Histone methylation and other modifications, initiated through a 
complex of DNA binding cofactors, deregulate A9. [Shah 2010, Thornsteindottir 2002]  
Similarly, B9 is associated with hematopoietic progenitor cells.  This particular gene is linked to 
the inhibition of prosurvival factors, resulting in progenitor apoptosis.  By inhibiting these 
pathways, progenitor cells were no longer able to survive, proliferate or differentiate. 
[Krishnaraju 1997] 
 However, paralog 8 and 9 genes of clusters A and D are not the only genes of these 
paralogs associated with carcinogenesis.  Hox C8, when overexpressed in prostate cancers, 
results in the loss of function of tumor differentiation.  This occurs through the suppression of 
androgen-mediated transcription. Androgen receptors are responsible for internalizing ligand 
hormones that function to bind DNA with these androgen-mediated transcription factors. 
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[Samuel 2005]  It has also been shown that Hox B6, B8, C8 and C9 are overexpressed during 
various stages of colorectal cancer. [Vider 1997]  The up-regulation of these genes was tested in 
11 different types of tumors, varying in progression from pre-malignant polyps to Dukes’ C 
metastatic tumors (see 1.4.2).  The results were compared to two non-colorectal tumors and to 
adjacent, non-tumorous, epithelial mucosa tissues.  Additionally, the results were confirmed with 
HT29 and Caco-2 cells.  The up-regulation of these genes coincided with a decrease in Cdx1.  
Cdx1, or caudal type homeobox 1, is a member of the caudal-related transcription factor gene 
family.  The encoded protein CDX1 regulates gene expression specific to the intestines and 
differentiation of enterocytes. [Vider 1997]  
 
1.4.1: The Colon 
 The colonic epithelium consists of crypts and villi.  The crypt contains approximately 250 
cells, while each villus is composed of nearly 
3,500 cells.  There are different cell types 
represented in both of these structures.  Stem cells, 
or undifferentiated cells, are confined to the crypts.  
As the cells progress out of the crypts, they 
undergo differentiation into one of the four types 
of cells present in the epithelium.  These 
differentiated cell types are: goblet, Paneth, 
enteroendocrine and absorptive cells [Figure 2].  
Each of the cell types possesses distinct functions 
within the colon.  For example, goblet cells are responsible for secreting mucin.  Mucin dissolves 
Figure 2. A schematic of the intestinal stem cell 
differentiating into the four possible cell types.  From 
left to right: absorptive (columnar/enterocytes), goblet, 
enteroendocrine and Paneth cells. Reprinted by 
permission from Macmillan Publishers Ltd: Nature 
Reviews Genetics (Crosnier 2006), copyright 2006 
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in water and forms the epithelial mucosa of the colon.  Paneth cells contribute to the maintenance 
of the gastrointestinal barrier by secreting anti-microbial substances into the lumen of the crypts, 
thus protecting the stem cells.  Enteroendocrine cells are smaller and secrete hormones such as 
peptides and catecholamines.  Absorptive cells, also known as enterocytes, are the only non-
secretory cells found in the epithelia of the intestine or colon.  These cells function in fluid 
transport, as well as ion, sugar, peptide, amino acid, lipid and 
vitamin B12 uptake.  They also reabsorb excess bile. [Crosnier 
2006] 
 In a “normally’ functioning system, cellular renewal 
from the stem cells into one of the four types occurs.  This is 
followed by the extrusion of the terminally differentiated cells 
into the lumen of the colon.  During or after extrusion, the cells 
undergo apoptosis.  This process usually occurs with 72 hours 
of the differentiated cell leaving the crypt. [Barnard 1993]  
However, in colorectal cancers the system goes awry and cells 
do not properly progress from the stem cells into differentiated 
cells.  Instead, neoplastic tissues form and the cells maintain an 
undifferentiated, proliferative state in which none of the four 
differentiated cell types are represented.  
 
1.5.1: The Model: HT29 
 The HT29 (ATCC: HTB-38) cell line is derived from a grade II human colon 
adenocarcinoma.  An adenocarcinoma is defined as a cancer of the epithelium of glandular 
Figure 3. The diagram displays the 
location of the different types of cells 
within the epithelium of the colon, in 
the crypts and villi.  Reprinted by 
permission from Macmillan 
Publishers Ltd: Nature Reviews 
Genetics (Crosnier 2006), copyright 
2006 
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tissues.  The classification of grade II refers to the stage of differentiation; II is an intermediate of 
moderately differentiated tumor.  Due to the proliferative abilities of these cells in culture, they 
provide an excellent model for investigating the role of Hox genes in oncogenesis.   
 In a proliferative, undifferentiated state, HT29 cells grow in nonpolar multi-layers [Le 
Bivic 1987].  However, when modulated, these cells begin to acquire a differentiated phenotype 
similar to that of goblet and/or absorptive epithelial cells.  These differentiated cells become 
polarized and grow as a monolayer.  In this differentiated state, tight junctions with adjacent cells 
form basolateral and apical domains. [Cohen 1999]  In vitro, differentiation is reversible 
dependent upon the environment.  The modulation of cellular environment, also known as 
induced differentiation, is performed along a gradient in order to ensure the cells are not shocked 
by sudden changes and thus enter into apoptotic pathways.  There are two common methods that 
are currently used in order to differentiate this cell line.  The first is by introducing a sugar other 
than glucose, galactose.  The second is by use of other chemicals, such as sodium butyrate or 
methotextrate.   
 Currently in this cell line, it is unknown which Hox genes are differentially expressed and 
whether there are direct role(s) of these genes on cellular fate.  However, more conclusive 
research has been conducted in another colon adenocarcinoma cell line, Caco-2 [Freschi 2005].  
Caco-2 (ATCC: HTB-37) exhibits similar morphological phenotypes upon differentiation.  
Differentiation in this cell line is referred to as spontaneous enterocytic differentiation, 
characterized by polarization, brush border formation and expression of hydrolases upon 
confluency in vitro.  They also grow in monolayers with some dome-cluster formation, like 
HT29.  It was observed that Hox genes of the A and C clusters are differentially expressed in the 
sister cell line, Caco-2 [Freschi 2005].  In normal adult colon tissue samples, Hox A genes are 
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expressed in proliferating cells of an undifferentiated nature in the base of the crypts of the 
epithelium.  The expression of Hox C genes is localized to the apex of the crypts of the colonic 
epithelia. [Freschi 2005] 
 Additionally, research has been conducted in colorectal cancer sample tissues from 
patients with familial adenomatous polyposis (FAP), Dukes’ A, B and C tumors.  Whereas FAP 
is usually an inherited condition in which benign polyps form on the epithelia of the colon, 
Dukes’ tumors are malignant tumors.  As malignancy indicates the ability of these tumors to 
metastasize, the Dukes’ system of tissue classification refers to the stage or progression of the 
cancer.  For example, A and B indicate that the cancer is established in the lining of the colon or 
has grown through the muscular layer.  C and D are indicative of metastases to the lymph nodes 
and/or other parts of the body, respectively. [Eschrich 2005, O’Connel 2004]  Using these 
tissues, the researchers identified possible deregulated Hox genes by nucleotide sequencing of 
RT-PCR detection products, in comparison to those of adjacent non-tumorous colonic mucosa 
tissues [Vider 2007].  It was determined that Hox B6, B8, C8 and C9 are up-regulated at various 
stages in the development of these cancers [Grier 2005, Vider 1997].  Following identification of 
up-regulated genes, the group verified their data in cell culture lines HT29 and Caco-2.  They 
also attributed the differentiated phenotypes of the cell lines to regulation of Cdx1 (see 1.2.3). 
[Vider 1997]  In addition to Cdx1, Cdx2 is linked to regulating intestine-specific gene expression 
and differentiation of enterocytes. [Guo 2004]  CDX2 is expressed in the development of the gut 
during embryogenesis and throughout adulthood.  CDX2 is a member of the homeobox family 
expressed in fully differentiated tissues.  In colorectal carcinomas, CDX2 loses protein 
expression. [Samuel 2005]  However, overexpression of this protein promotes intestinal cell 
differentiation and marked decrease in the ability to proliferate [Abate-Shen 2002] 
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1.5.2: The Model: Induction of Differentiation and its Implications 
 As previously mentioned, differentiation of cells can be induced by certain types of 
treatment.  In the HT29 cell line, because the cells are derived from a moderately differentiated 
tissue, they possess some features of differentiated cells.  The American Type Culture Collection 
from which this cell line was obtained states that one of the observed ultrastructural features 
includes microvilli and that mucin expression is present.  Both of these characteristics are also 
associated with differentiated cells.  However, they are not fully differentiated.  They still 
possess the ability to become one of the four types of cells found present in the epithelium of the 
colon. [ATCC, Crosnier 2006, Huet 1967] 
 The mechanisms by which differentiation can be induced are not yet fully understood.  
Researchers Augeron and Laboisse stated that cancer cells of a somatic nature, or cells not 
related to reproductive tissues and organs, are useful models for studying induced differentiation 
roles and cellular characteristics.  These cancer cells are classified into three general categories 
based on their abilities to differentiate due to 1) nutritional condition changes, 2) short-term 
treatment with chemicals, or 3) response to naturally occurring chemicals found within the body. 
[Augeron 1984]  For this research, the mechanism of choice was treatment with a chemical 
known as sodium butyrate (NaBT).  Sodium butyrate is a known histone deacetylase inhibitor. 
[McCue 1984]  Acetylation and deacetylation of histones occurs on the lysine residues.  When 
the histone is acetylated, usually by an enzyme known as acetyltransferase, the chromatin is 
loosely packed or in an “open” conformation.  This allows for transcription and other processes 
to occur.  If the histone is deacetylated, by the enzyme deacetylase, the histone is in a “closed” 
position and the chromatin is densely packed.  These processes of acetylation and deacetylation 
are highly regulated. [Privalsky 1998, Ruijter 2003]   
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While not specific to HT29, in mouse embryonic carcinoma cells treated with NaBT 
showed a marked increase of acetylation on histones 3 and 4 (H3 and H4). [McCue 1984]   
 
 
 The goal of this research was to determine the effects of sodium butyrate, known histone 
deacetylase inhibitor on Hox gene expression in human adenocarcinoma colorectal cancer cell 
line, HT29.  The hypothesis was that Hox genes expressed only in untreated HT29 cells are 
responsible for maintaining the proliferative, undifferentiated state of these cells.  The first 
objective was to identify the pattern of expression of all 39 Hox genes in untreated and sodium 
butyrate treated HT29 cells by use of reverse transcription polymerase chain reaction (RT-PCR).  
Due to the role of sodium butyrate as a possible differentiating agent, the second objective was to 
target select genes with a distinctive pattern of expression that may play a role in maintaining the 
undifferentiated state of the tissue.  For example, these genes would be expressed in untreated 
HT29, but not treated HT29.  The expression of these targeted genes were quantitatively 
analyzed by use of quantitative real-time PCR (qRT-PCR), normalized against housekeeping 
genes.  The protein expression of these targeted genes were also studied by use of Western blot.  
Additionally, another objective was to determine the effects of sodium butyrate on the cellular 
phenotype.  If the sodium butyrate was effectively differentiating the treated HT29 cells, the cells 
should exhibit phenotypes similar to that of one of the four cell types found in the epithelium of 
the colon.  These phenotypes include the formation of brush borders, apical and basolateral 
domains, and tight junctions.  This was performed by ultrastructural analysis of untreated and 
NaBT treated HT29 cells in transmission electron microscopy (TEM). 
 Chapter 2: Materials and Methods 
The following techniques were applied to this research and were carried out within 
laboratories of the Howell Science Complex at East Carolina University. 
 
2.1.1: Cell Culture: Untreated HT29 
 The HT29 cells (ATCC: HTB-38) were cultivated in Dulbecco’s Modified Eagle 
Medium (DMEM/F12) (Gibco 113300), supplemented with 10% fetal bovine serum (FBS), 100 
U penicillin/100 µg streptomycin (Gibco 15140) and 1 mM sodium pyruvate (Gibco 11360).   
 The cells were maintained in medium and split upon 60-75% confluency.  Splitting was 
done by washing the cells with 1X PBS (Phosphate Buffered Saline) upon aspirating and 
discarding the media.  The cells were rinsed with 0.5% Trypsin/EDTA and incubated at room 
temperature until the cells detached from the flasks.  The cells were resuspended in fresh 
DMEM/F12 and seeded into new flasks.  The media was changed every other day. 
 
2.1.2: Cell Culture: Sodium butyrate-treated HT29 
 For sodium butyrate-treated HT29 cells, a media containing sodium butyrate was used.  
The treated HT29 cells were cultivated in DMEM/F12, supplemented with 10% FBS, 100 U 
penicillin/100 µg streptomycin, 1 mM sodium pyruvate and 5 mM sodium butyrate (Sigma-
Aldrich B5887).  The introduction of sodium butyrate (NaBT) media in treating these cells was 
performed following the guidelines of Table 1. 
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Table 1. Treatment of HT29 cells with sodium butyrate containing media. Adapted. [Augeron et. al 1984] 
Day of Treatment Media Conditions 
Days 0-1 Standard Media (DMEM/F12)  
Days 2-7 5 mM Sodium butyrate supplemented DMEM/F12 
 
 Day 0 indicates the day on which the cells (untreated) were split and seeded into new 
flasks by the same previous methods.  However, for sodium butyrate treatment, the densities of 
seeding are as follows: 
T25: 1.5-2.0 x 106 cells per flask 
T75: 6.0 x 106 cells per flask 
35 mm petri dish: 7.7 x 105 cells per dish 
Other sizes: 10,000 cells/cm2 
 
Control untreated HT29 cells were also seeded at the same densities.  The NaBT media 
was changed on days 1, 2, 3, and 5 of each respective treatment.   
 
2.1.3: Cell Culture: Cell Growth Curves 
 In order to determine the number of cells present in a flask on varying days of growth 
after seeding, cell growth curves were used.  This procedure was also a good indicator of cellular 
proliferation and/or death during NaBT treatment.  The untreated HT29 cells served as the 
control. 
 On Day 0, 9.6 x 104 HT29 cells were seeded into 35 mm petri dishes.  For a seven-day 
growth curve, each day had three replicates of each untreated and treated HT29.  Over the course 
of the seven days, the untreated HT29 were maintained with fresh media every other day (see 
2.1.1).  The NaBT treated HT29 cells were maintained with the supplemented media as 
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previously stated (see 2.1.2).  On days 1, 2, 3, 5 and 7, the replicates of both untreated and 
treated cells were counted. 
 The media was removed from the petri dishes and discarded.  The cells were rinsed with 
1X PBS and 1 mL 0.05% trypsin/EDTA was pipetted into the petri dish.  Allowing enough time 
incubating for the cells to detach, fresh media was added to the existing trypsin/cell suspension.  
The volume was dependent upon the number of cells in the petri; initially, 1 mL was sufficient, 
progressing to 2 mL toward the end of the seven-day period.  The mixture was pipetted well in 
order to break apart clumps of cells.  50 µL of cell suspension was transferred from the petri dish 
to a 1.5 mL microcentrifuge tube.  5 µL Trypan Blue dye was added to the tube, in addition to 45 
µL of 1X PBS.  The sample was triturated by use of pipet and 20 µL was loaded into a 
haematocytometer.  The cells were then counted and the procedure was repeated for all of the 
petri dishes harvested.   
 
2.2.1: RT-PCR: RNA Extraction 
Cells were lysed and total RNA was extracted with the Qiagen™ RNeasy™ kit following 
manufacturer’s instructions with slight modifications.   
First, the HT29 cells were seeded in a T75 flask at a density of 6 x 106 cells.  The flasks 
were then sodium butyrate treated (see 2.1.2).  On day 4 of treatment, untreated HT29 cells were 
seeded at the same density of 6 x 106 cells and maintained (see 2.1.1).  On day 7, both the 
untreated and treated flasks were harvested for RNA extraction.  The media was aspirated and 
discarded, and the cells were rinsed with 1X PBS.  The flasks of cells were then lysed with RLT 
lysis buffer by scraping with a rubber policeman.  The lysate was pipetted into tubes at a volume 
of ~500 µL, each.  Each tube of lysate was homogenized through an RNase-free 21½ gauge 
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sterile needle, by aspiration 6-7 times.  1 volume of 70% ethanol was added to each tube of 
lysate, mixed and transferred to a spin column.  The samples will be centrifuged for 15 seconds 
at 10,000 rpm and the flow-through will be discarded.  This step was repeated until all of the 
sample was added.  At this step, an optional RNA DNase treatment was performed.  350 µL 
buffer RWI was added to the column, followed by centrifugation for 15 seconds at 10,000 rpm; 
the flow-through will be discarded.  10 µL DNase I stock solution was mixed with 70 µL buffer 
RDD in a new PCR reaction tube; the mixture was then briefly centrifuged.  The sample was 
loaded onto the column and incubated on the bench top for 15 minutes.  Following this 
incubation, 350 µL buffer RWI was added to the column and centrifuged at 10,000 rpm for 15 
seconds.  The flow-through was discarded.  Following DNase treatment, 500 µL of RPE buffer 
was added and centrifuged for 2 minutes at 10,000 rpm.  The flow-through was again discarded 
and followed by centrifugation for 1 minute at 10,000 rpm in order to remove residual ethanol.  
The column was transferred to a fresh tube; RNA was eluted with 30 µL RNase-free water and 
again centrifuged for 2 minutes at 10,000 rpm.  If the optional on-column DNase treatment was 
not performed, an off-column DNase treatment was performed after RNA elution.  The eluted 
RNA was DNase treated with 0.1 of RNA volume 10X Turbo buffer and 1 µL Turbo DNase.  
The RNA was incubated at 37°C for 30 minutes.  Then, 0.1 volume inactivation reagent was 
added, mixed constantly, and incubated at room temperature for 5 minutes.  Following the 
incubation, the sample was centrifuged at 10,000 x g for 1.5 minutes.  The supernatant was 
removed and put into a new tube and was used for quantification.  The pellet was discarded. 
After determining the concentration using the ThermoScientific NanoDrop™ 2000 
Spectrophotometer and NanoDrop software, the RNA was stored at -80°C. 
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2.2.2: RT-PCR: cDNA Synthesis 
In a PCR tube, 1 µg RNA, 1 µL 10 mM dNTPs, 1 µL random hexamer primers, and water 
to a total volume of 10 µL was mixed. The mixture was incubated at 65°C for 5 minutes.  The 
samples were cooled briefly on ice, centrifuged, and a mixture of the following was added:  4 µL 
5X First Strand Buffer, 2 µL 0.1 M DTT, and 1 µL RNaseOUT™.   The sample was incubated at 
25°C for 2 minutes, followed by the addition 1 µL SuperScript™ II RT. 
 The sample was incubated at 25°C for 10 minutes, followed by 42°C for 50 minutes and 
70°C for 15 minutes.  1 µL of 2 U/µL E. coli RNase H is added and incubated for 20 minutes at 
37°C.   
The cDNA was cleaned using the Qiagen™ MinElute™ kit.  Five volumes of buffer PB 
was added to the cDNA and loaded onto a to a MinElute™ column.  The column was 
centrifuged at 13,000 rpm for 1 minute and the flow-through is discarded.  Then, 750 µL buffer 
PE was added to the column and centrifuged at 13,000 rpm for 1 minute and the flow-through 
was discarded.  A dry spin followed with centrifugation for 1 minute at 13,000 rpm.  The column 
was transferred to a new tube, 10 µL RNase-free UltraPure water was added and incubated on 
the benchtop for 10 minutes at room temperature.  The cDNA was eluted by centrifugation for 1 
minute at 13,000 rpm.  The final volume was adjusted to 20 µL with RNase-free UltraPure water.  
The NanoDrop software was used to determine the concentration of the cDNA.  The cDNA was 
stored at -20°C. 
 
2.2.3: RT-PCR: Genomic DNA Extraction 
In order to test primers or cDNA samples for genomic contamination, genomic DNA 
extractions were performed.  The cells were lysed with SB lysis buffer (containing 50 mM 
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HEPES (pH 7.5), 150 mM NaCl, 1 mM MgCl2, 1.5 mM EDTA, 0.5% Triton X-100, 20 mM β-
glycerolphosphate, 100 mM NaF, 0.1 mM PMSF) and scraped with a rubber policeman.  The 
contents were then transferred to a 1.5 mL tube.  2 µL 10 µg/mL proteinase K was added to the 
sample, mixed and incubated in a 50°C water bath for 2 hours. 
 1 volume PCI (25:24:1 phenol chloroform isoamyl alcohol) was added to the tube and 
centrifuged at 12,000 rpm for 5 minutes. The aqueous layer was carefully removed and 
transferred to a new tube, repeating the procedure above.  To the isolated aqueous solution, 4 
volumes of 0.3 M potassium acetate were added, followed by two volumes ethanol and stored at 
-20°C overnight.  The tube was centrifuged for 5 minutes at 12,000 rpm.  The DNA pellet was 
then washed with 70% ethanol and centrifuged.  The DNA was dried, resuspended in 50 µL 
0.5% Tris/EDTA and incubated overnight at 37°C.  The concentration will be quantified using 
NanoDrop software as before and the gDNA was stored at -20°C. 
 
2.2.4: RT-PCR: Preparation and Analysis 
Reverse transcriptase polymerase chain reaction (RT-PCR) was used to determine the 
pattern of expression of Hox genes in both untreated and treated HT29 cells.   
A mixture of the following was prepared: 1 µL cDNA, 2.5 µL 10X PCR, 0.75 µL 50 mM 
MgCl2, 0.5 µL 10 mM dNTPs, 2.5 µL respective 3 pmol/µL primer F, 2.5 µL respective 3 
pmol/µL primer R, and the volume was adjusted to 20 µL with RNase-free UltraPure water; 
finally, 0.65 U Taq polymerase was added.   
 ß-actin was used as the positive and negative controls; the negative control contained no 
cDNA template, instead replacing that volume with additional water.  The mixtures were then 
processed in the Thermalcycler for the following cycles: 
 19 
  Step 1: 94°C 00:04:00 
  Step 2: 94°C 00:01:00 
  Step 3: **°C 00:00:45 
  Step 4: 74°C 00:01:00 
  Step 5: go to step 2, x 39 
  Step 6: 74°C 00:10:00 
  Step 7: 15°C hold step 
 The annealing temperature** for each mixture was specific to the set of primers used. 
(Table 2) 
Following RT-PCR amplification, the products were analyzed with gel electrophoresis.  
Using 0.75 grams of agarose, a 1.5% gel was prepared with 50 mL 1X TAE buffer (Tris 
base/acetic acid/ethylenediamminetetraacetic acid:  3.3 M TrisBase, 50 mL 0.5 M EDTA, 55 mL 
glacial acetic acid, brought to a final volume of 500 mL with ddH2O).  
 Once the gel electrophoresed, it was drained of buffer and photographed with a Kodak 
1D-imaging device using Carestream Imaging software. 
 
Table 2. Primers, cDNA sizes, corresponding annealing temperatures.  Primers highlighted in gray indicate intron-
flanking sequences.  *Primers A3, A4 and D11 were purchased from Santa Cruz Biotechnology, Inc. and the sequences 
are considered proprietary. 
Hox Gene Size (bp) Temperature (°C) Primer Pair Sequences 
A1 360 60.5 
+GGCGTGGAGAGGGGACAAGGAG 
-CACCACCACCACCACCACCATC 
A2 102 54 
+ACAGCGAAGGGAAATGTAAAAAGC 
-GGGCCCCAGAGACGTAA 
A3 470 60 ** 
A4 559 54 ** 
A5 293 55 
+CCCCTCTCTGCTGCTGATG 
-CCATTGTAGCCGTAGCCGT 
A6 511 63.1 
+CCGGGAGCCTTCCCAGCGGC 
-GCGGCGCCGTGTCAGGTACGC 
A7 225 55 +GGGGATGTTTTGGTCGTA 
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-GCGGGGGCTTCTCTGTTC 
A9 549 55 
+ATGGAGGAGGTATTGTAATGC 
-CCCGCATTTTTAAGGTGGAG 
A10 542 55 
+GTGAAAACGCAGCCAACTGG 
-CAGGACTTGACACTTAGGAC 
A11 415 55 
+AGCAAATCCACTCCTCTAAG 
-GCTTTTTTACTCAGGGGTCC 
A13 233 55 
+CTGGAACGGCCAAATGTACT 
-AGAGATTCGTCGTGGCTGAT 
B1 260 56 
+CCTCGGGGTATGCTCCTG 
-GGGTGTTTCCTTGTCCTC 
B2 145 50 
+CCTTCCCCGCTGTCTTGG 
-GCTCGCTTTTGGCTCCTG 
B3 227 50 
+CCCCCAACCCCCATTTCA 
-CGCCCCCATTACTGCTGT 
B4 161 60 
+GTGCAAAGAGCCCGTCGTCTACC 
-CGTGTCAGGTAGCGGTTGTAGTG 
B5 659 58 
+GCTCTTACGGCTACAATTACAATG 
-GCTCAGCCAGGCTCATACT 
B6 225 56 
+AAGAGCAGAAGTGCTCCACT 
-TGATCTGCCTCTCCGTCA 
B7 459 60 
+CGGGCGCTTCCTTCGCCGCC 
-CCCGGGCCCGCGGTCTTGTTC 
B8 291 55 
+TTCTACGGCTACGACCCGCT 
-CGTGCGATACCTCGATTCGC 
B9 600 55 
+CCTTTGCCCTTACCTGTCTC 
-GCTCCACCTAAGATAGCTTC 
B13 544 60 
+TGACCAGCCACCCAGCGGCG 
-TGCGGCCGCGACGAAAGGCG 
C4 510 64.2 
+CACCGCCTCCGCGCCCTAGC 
-CGGCCGGGGGTGCTGACCTG 
C5 481 56.6 
+TCCTCCCCAACGTCGCCCTC 
-TGTCGCTCGGTCAGGCAAAGC 
C6 317 58 
+CACCTTAGGACATAACACACAGACC 
-CACTTCATCCGGCGGTTCTGGAACC 
C8 267 55 
+TCAGAGCGTGGGCAGGAG 
-GCGGAGGATTTACAGTCG 
C9 114 60 
+ACGAGGAAGAAGCGCTGCCCC 
-GAGAACCCGGGCCACCTCATA 
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C10 369 55 
+CCTCCTGCTCCTACCCACCTA 
-GGCTCGGTCCGTCTTGATTT 
C11 195 55 
+CCTCCTTCCACCGTCACC 
-GTCGCCGCCACCGCAGTA 
C12 124 60 
+TAATCTCCTGAATCCCGGGTTT 
-TGGGTAGGACAGCGAAGGC 
C13 417 60 
+TGTCGCACAACGTGAACCTG 
-CTTCAGCTGCACCTTAGTGTAG 
D1 210 57 
+TTCAGCACGTTCGAGTGGAT 
-TGCGTGTCATTCAGGTGCAA 
D3 187 54 
+CATCAGCAAGCAGATCTTC 
-AGCGGTTGAAGTGGAATTC 
D4 271 56 
+TGGATGAAGAAGGTGCACGT 
-TAGAGTTTGGAAGCGACTGT 
D8 219 56 
+GGATACGATAACTTACAGAGAC 
-TAGAGTTTGGAAGCGACTGT 
D9 285 56 
+GAGTTCTCGTGCAACTCGT 
-CAGCTCAAGCGTCTGGTAT 
D10 541 50 
+CCTACAAAGGACACAATCTC 
-GTACTCTTGGGTTTTCCCGG 
D11 549 64 ** 
D12 383 57 
+AGCAGGCTAAGTTCTATGCG 
-CAATCTGCTGCTTCGTGTAG 
D13 407 52 
+CCCCCAGCCAAAGAGTGC 
-CCGTTAGCCAGCGTCCAG 
 
 
2.3.1: qRT-PCR: Cells-to-CT Preparation 
 qRT-PCR was used to quantitatively determine the levels of expression of Hox D8 and 
D9 when normalized to a battery of housekeeping genes in both untreated and sodium butyrate 
treated HT29 cells.   
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 Untreated and treated HT29 cells were harvested and prepared for qRT-PCR following 
manufacturer’s guidelines with slight modifications using the Applied Biosystems Power 
SYBR® Green Cells-to-CT™ kit (Life Technologies 4402953M).  
 On Day 0, 6 x 106 cells were seeded into each of five T75 flasks to begin sodium butyrate 
treatment (see 2.1.2).  On day 4 of treatment, untreated cells were seeded into five T75 flasks at 
the same starting density of 6 x 106 cells per flask, in order to ensure the cells were in a 
proliferative state at the time of harvesting.  On day 7 of treatment and maintenance, both sets of 
cells (untreated and treated) were collected and a cell count was performed for each flask.  The 
cells were first washed with 1X PBS after aspirating and discarding the media.  The PBS was 
then removed and 2 mL of 0.05% trypsin/EDTA was pipetted into each flask.  The cells were 
rinsed with the solution and it was removed.  Into each flask, 2 mL of 0.05% trypsin/EDTA was 
added and the cells were incubated for a few minutes until detached.  One mL of fresh DMEM 
was added to the flask to inactivate the trypsin/EDTA and the contents were transferred into 10 
respective 15 mL conical tubes.  The tubes were centrifuged to pellet the cells.  The supernatant 
solution was aspirated, leaving the pellet to be suspended in 1-5 mL dependent upon pellet size.  
During the preparation and count, the cells were kept on ice. After performing the cell count and 
calculating the number of cells in each suspension, the cells were then pelleted in the centrifuge 
again.  The supernatant was removed and the cells were washed in 4°C 1X PBS at a volume of 
0.5 mL per 106 cells. The cells were again gently pelleted and the supernatant PBS was removed. 
The cells were kept on ice and resuspened in 4°C 1X PBS so that 5 µL contained 105 cells.  The 
5 µL volume of PBS/cells was transferred to a 0.250 mL nuclease/RNase-free PCR reaction tube.  
Each respective tube was labeled according to treatment type: treated or untreated, and flask 
number.   
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 A DNase I 1:100 lysis core solution was prepared for each tube.   
  49.5 µL lysis buffer 
  0.5 µL DNase I 
 
When calculating the total core volume (the above volumes are per tube), a 10% overage was 
factored in.  To each PCR reaction tube of cells in 1X PBS, 50 µL of the DNase I lysis solution 
was added and pipetted to mix 5 times, ensuring no bubble formation.  The tubes were then 
incubated at room temperature for 5 minutes.  To each of the tubes, 5 µL of stop solution was 
added and pipetted to mix 5 times, ensuring no bubble formation.  The tubes were incubated at 
room temperature for 2 minutes.  The lysates could be stored on ice up to 2 hours or at -20°C or  
-80°C for up to five months.   
 An RT Master Mix core was prepared for transcribing lysates to cDNA, allowing for a 
10% overage, the volumes below are per tube.   
  25 µL 2X SYBR RT Buffer 
  2.5 µL 20 X RT Enzyme Mix 
  12.5 µL Nuclease-free H2O 
The mix was kept on ice until use.  For each reaction, 10 µL of prepared lysate was added to 40 
µL of the RT Master Mix in a 0.250 mL PCR reaction tube.  The reactions were then mixed 
gently by pipetting and briefly centrifuged to collect at the bottom.  The tubes were incubated at 
37°C for 60 minutes for the reverse transcription step, followed by an incubation at 95°C for 5 
minutes to inactivate.  The cDNA could then be held at 4°C for immediate use or -20°C for 
storage.   
 
2.3.2: qRT-PCR: Templates, Plate Loading, Performing the Trials  
The template, called RT reaction (cDNA), was prepared for the trials of qRT-PCR by 
diluting into 1:4, 1:20 and 1:100 with UltraPure water (Gibco 10977-023).   
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 For each gene, D8, D9 and the seven housekeeping genes, three trials were performed.  
Each trial was untreated and treated template in the three varying dilutions, with three replicates 
per dilution.  For each gene, a Power SYBR core mix was prepared, with a 10% overage 
calculated.  The volumes below are per well of a 96-well PCR plate. 
  10 µL Power SYBR Master Mix 
  1 µL forward primer 
  1 µL reverse primer 
  4 µL Nuclease-free H2O  
Because the Power SYBR Green Master Mix is light sensitive, the exposure to light was kept as 
minimal as possible.  The core was prepared in a 0.250 mL nuclease/RNase-free PCR reaction 
tube.  The core tubes were kept on ice until use.  From each Power SYBR core, 16 µL was 
pipetted into each of the wells needed in a 96-well PCR plate.  To each well containing the core 
mixture, 4 µL of the respective diluted template was added and mixed by pipetting.  The diagram 
below depicts the way the plates were loaded for the gene being tested (Figure 4).  All three trials 
for each gene of interest were tested on the same plate. 
 
Figure 4. Diagram of the 96-well PCR plate.  Darkened wells represent blank or unused wells.  Each of the three trials on 
the plate contains 1 untreated (UT) row and 1 treated (T) row.  There are three replicates for each dilution outlined. 
The plate was then sealed using Biorad Microfilm ‘B’.  Using a Biorad C1000 Thermalcycler 
and corresponding software, Biorad CFX96 Real-time PCR Detection System, the plates will be 
run using the following settings: 
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  Step 1: 95°C 00:10:00 
  Step 2: 95°C 00:00:15 
  Step 3: **°C 00:01:00 + plate read 
  Step 4: go to step 2, x 39  
  Step 5: melt curve 65-95°C at 0.5°C increments for 5 seconds + plate read  
The asterisks(**) in step 3 denote that the temperature used was primer specific. (Table 3) In 
addition, negative controls that replaced the template volume with water were run for each gene 
of interest and housekeeping gene.  Once used, the plates were stored at -20°C and the output 
data was used for analyses with Pfaffl. 
Table 3. qRT-PCR primer sequences, annealing temperatures and amplicon sizes for two sets of designed Hox paralog 8 
and 9 genes and housekeeping genes.  The asterisks (**) denote the two primer pairs used for D8 and D9 gene of interest 
trials.  The (-) denotes genes for which conditions were not tested or are unknown. 
Gene Identification Primer Pair Sequence Tm (°C) Amplicon Size (bp) 
A9 
Forward1 CCGCGGATGAGCTGAGCGTT 
55 103 
Reverse1 CTGCACGGGCTGAAGTCGGG 
Forward2 GAGAGCGGCGGAGACAAGCC 
55 75 
Reverse2 CCGAGTGGAGCGCGCATGAA 
B8 
Forward1 TTCTGTGTGTGAGCTACCGTGGAT 
60 84 
Reverse1 CGAGGGAGCCTTTGCTTAAATCCT 
Forward2 CAGAACCGGAGGATGAAGTGGAAA 
- 154 
Reverse2 AAGCCTACTTCTTGTCGCCCTTCT 
B9 
Forward1 TGCAAATACCCACCAGGGAGATGT 
60 90 
Reverse1 ATGGGAATGGTATGGCAATGCTGC 
Forward2 CGCGTCCGAAAGCCCTCACAC 
- 98 
Reverse2 ATTATCCGGGCGCTTGCAGGG 
C8 
Forward1 AACTGTCTCCCAGCCTCAGTTT 
60 86 
Reverse1 TGATACCGGCTGTAAGTTTGCCGT 
Forward2 TGGAAACCTGAAGGAGATGTGGGT 
- 138 
Reverse2 AAACAGCGAAGGAGAGGAAGGCAT 
C9 
Forward1 TCTTGCGATTTGGGAGGGTTCAGT 
- 122 
Reverse1 GTCATTTATTTCGGTTGCGCTGGG 
Forward2 ACAATGAAGACCTCCTAGCGTCCA 
- 94 
Reverse2 AAATCGCTACAGTCCGGCACCAAA 
D8 
Forward1 ACTTGTAGTCCAGCTCTGCAGCTT 
65 142 
Reverse1 TACAAGGCGATTTGCCAGAGTTGC 
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Forward2** TCGCTAGTTCTTTATGCGGTGGCT 
65 91 
Reverse2** GCGGCGAACAGAACAAAGGCAATA 
D9 
Forward1** AGCAGCAACTTGACCCAAACAACC 
65 107 
Reverse1** TTTCTCCAGCTCAAGCGTCTGGTA 
Forward2 GCGAACTAGTCGGTGGCTCGG 
65 80 
Reverse2 CGTCCCGCACTCCCACCCAA 
TFRC 
Forward AGGTCGCTGGTCAGTTCGTGATTA 
60 82 
Reverse AGCAGTTGGCTGTTGTACCTCTCA 
ACTB 
Forward AATGTGGCCGAGGACTTTGATTGC 
63 93 
Reverse AGGATGGCAAGGGACTTCCTGTAA 
B2M 
Forward AGATGAGTATGCCTGCCTGTGAA 
57 82 
Reverse TGCTGCTTACATGTCTCGATCCCA 
GAPDH 
Forward GAAGGTGAAGGTCGGAGTCAAC 
66 70 
Reverse CAGAGTTAAAAGCAGCCCTGGT 
TBP 
Forward TGATGCCTTATGGCACTGGACTGA 
60 86 
Reverse CTGCTGCCTTTGTTGCTCTTCCAA 
RPL13a 
Forward CCTGGAGGAGAAGAGGAAAGAGA 
57 125 
Reverse TTGAGGACCTCTGTGTATTTGTCAA 
RPLP0 
Forward GCAATGTTGCCAGTGTCTG 
60 - 
 GCCTTGACCTTTTCAGCAA 
 
   
2.3.3: qRT-PCR: Pfaffl Analysis 
The output data from qRT-PCR was not in a form that was ready to be interpreted.  In 
order to analyze the results, the data was first manipulated.  The method for calculation is known 
as the Pfaffl method. [Livak 2001, Pfaffl 2001] 
For each gene, both genes of interest (targets) and housekeeping (reference), the Biorad 
CFX Manager software provided a CT value, or value at which the level of fluorescence 
exceeded the background levels and was detected.  The CT value for each replicate of each 
dilution was averaged.  For example: 
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CT(avg)= 
(CT1+CT2+CT3) 
Number of Replicates 
 
CT data for a 1:4 dilution may have read: 24.30, 24.29 and 24.28.  These values were averaged 
together:  (24.30+24.29+24.28)/3 = 24.29, and this averaged value was used for further 
calculation. 
A ∆CT value was calculated for each dilution of the genes of interest (∆CT(goi)) and 
reference genes (∆CT(hkpg ).  For example: 
  
∆CT(hkpg) 
= 
CT(avg) untreated housekeeping gene - CT(avg) treated housekeeping gene  
∆CT(goi)  
= 
CT(avg) untreated gene of interest - CT(avg) treated gene of interest 
These values were then used to determine the Pfaffl equation top and bottom lines.  It is 
important to note here that the efficiency, when 100%, was equal to “2”.  If the efficiency was 
not equal to 100%, for example 94%, the value used was equal to “1.94”.   
  
 
 
The ratio was then the normalized level of expression of the treated gene of interest in 
comparison to the untreated gene of interest.  This ratio was calculated for each dilution of each 
gene of interest against all of the reference genes.   
 The relative or normalized ratio was compared for each gene of interest, D8 and D9, to a 
housekeeping gene that was similar in CT if available, and different in CT. (Appendix A) 
Ratio = 
(Etarget)∆CT(untreated-treated) 
(Ereference)∆CT(untreated-treated) 
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2.4.1: Transmission Electron Microscopy: Preparation of Solutions 
 Transmission electron microscopy was used to analyze the ultrastructural features of the 
untreated and sodium butyrate treated cells.   
 To prepare the Electron Microscopy Sciences® Embed™ Resin, 20 grams ERL-4221 
(EMS®), 16 grams DER736 Epoxy Resin (EMS®), 50 grams NSA (EMS®), and 0.6 g DMAE 
(EMS®) were added together and stirred with a stir bar for 10 minutes.  This solution was 
prepared right before use to prevent any hardening and was covered with Parafilm in order to 
prevent contamination. 
 To prepare the 0.1 M sodium cacodylate buffer, 250 mL distilled water was added to 250 
mL 0.2 M sodium cacodylate buffer donated by the laboratory of Randall R. Renegar, PhD at the 
Brody School of Medicine department of Anatomy and Cell Biology.  This solution was stored at 
4°C until use. 
 To prepare the osmium tetroxide, one OsO4 ampoule (EMS®) was added to 5 mL of 
distilled water and heated to dissolve.  To this sample, 5 mL of prepared 0.1 M sodium  
cacodylate buffer was added and inverted to mix.  This solution was stored at 4°C until use. 
 To prepare the 2% glutaraldehyde, one 10 mL ampoule of 50% glutaraldehyde (EMS®) 
was added to 240 mL of prepared 0.1 M sodium cacodylate buffer.  This solution was stored at 
4°C until use. 
 
2.4.2: Transmission Electron Microscopy: Preparation of Cells 
The cells were grown on 0.4 µm porous polyethylene terepthalate membrane (BD Falcon 
35-3090) inserts placed in 6-well tissue culture treated plates.  Sodium butyrate treated HT29 
 29 
cells were seeded on the membranes and treated as previously stated in sodium butyrate 
supplemented DMEM/F12 (see 2.1.2).  On day 5 of sodium butyrate treatment, the untreated 
HT29 cells were seeded (see 2.1.1).  The cells were stored in a 37°C incubator + 5% CO2.  On 
day 7, both the untreated and treated cells were rinsed with 1X PBS and prepared for 
transmission electron microscopy (TEM). 
The first fixation was performed with cold 2.0% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for 30 minutes at room temperature.  This initial fix was done leaving the 
membranes in the 6-well plate, working under the hood. The first buffer wash was with cold 0.1 
M sodium cacodylate buffer, incubated at room temperature for 10 minutes. The buffer was 
removed and the wash was repeated two more times.  The membranes were then postfixed using 
1% osmium tetroxide (OsO4) in 0.1 M sodium cacodylate buffer for 30 minutes, and was kept 
under the hood for the entirety of the incubation.  The osmium tetroxide was then removed and 
the membrane was washed with 0.1 M sodium cacodylate buffer for ten minutes.  The wash was 
repeated two additional times at room temperature. The membrane inserts were then transferred 
to new chambers of the 6-well plate to ensure no remaining water was introduced during 
dehydration.  The first dehydration was with 30% ethanol for 10 minutes.  During the 
dehydration steps, it was essential to leave the lid on the 6-well plate to reduce the introduction 
of environmental water into the system. Dehydration continued with the following ethanol 
variations, each for 10 minutes: 70%, 95% and 100%.  Finally, dehydration was completed two 
washes in 100% ethanol for 20 minutes each.  After the last dehydration step, the resin 
embedding procedures were performed on a shaker table to ensure the mixture was covering all 
parts of the membrane constantly. The epoxy used was Electron Microscopy Sciences® 
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Embed™ Resin.  The membranes were embedded in increasing ratios of resin to 100% ethanol, 
as follows: 
 1 part Embed™ Resin to 2 parts ethanol x 30 minutes 
 2 parts Embed™ Resin to 1 part ethanol x 1 hour 
 3 parts Embed™ Resin with no ethanol x 1 hour, repeating three times total 
After washing the membranes in resin, the final wash was removed from the membranes and the 
membranes were sectioned using fine-tipped scalpels.  
The trimmed samples of membrane were placed into one of three different molds for 
embedding: BEEM capsule lids; flat, thin molds; or pyramidal shaped molds.  The membranes 
were pushed firmly toward the bottom of each of the specific molds using an insect pin, 
carefully, as to not disturb the cells on the surface.  The samples were pushed down so that the 
membrane was at the top of the block face and cells below so that blocks could be faced with the 
ultramicrotome without cutting away the cells.  Membrane segments were embedded in the 
Electron Microscopy Sciences® Embed™ Resin. 
An RMC MT6000-XL Ultramicrotome was used to obtain both thick and thin sections.  
The sections were cut with glass knives made with a Reicherto-Jung KnifeMaker II.  Thick 
sections were mounted to glass microscope slides using EMS Permount.  The sections were then 
imaged using a Leica CME phase contrast microscope.  Thin sections were first expanded with 
toluene and then collected using a fine wire transfer loop to flame-sterilized 400 hexagonal mesh 
grids.  For these particular preparations, thick sections were collected at a 990 nanometer 
thickness, while thin sections varied from 75-290 nanometers.  Once dried, the grids were 
transferred to a multi-grid staining holder.  The grids were stained with filtered uranyl acetate for 
10 minutes at room temperature.  Following staining, the grids were washed 3 times in distilled 
water, drying with a paper towel and Kimwipe between each rinse.  The grids were then stained 
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with lead citrate in the dark in the presence of sodium hydroxide for 10 minutes.  Following this 
second stain, the grids were washed 4 times with distilled water, again drying the grids between 
each rinse.  One final wash in distilled water was performed and the grids were then dried.  The 
grids were transferred to a piece of filter paper in a petri dish and left to dry completely.  
The grids were stored until use, and then loaded into the Philips CM12 Transmission 
Electron Microscope for viewing and imaging.  Micrographs for untreated HT29 cells were film 
negatives, which were then developed for analysis.  Micrographs for treated HT29 cells were 
taken with AMT Custom Engineered Optics XR50 Digital Camera and analyzed using the 
imaging software AMT Image Capture Engine V602. 
 
2.5.1: Western Blot: Preparation of Solutions 
In order to determine if Hox D8 and D9 proteins are present in both untreated and treated 
HT29, and to further investigate their pattern of expression, Western blotting was performed.  To 
perform these experiments, a number of solutions were first prepared. (Table 4)  
 
Table 4.  Necessary solutions prepared for Western blotting: RIPA lysis buffer for preparing cell lysates; 2X Laemmli 
buffer for a loading dye; transfer buffer for transferring the proteins from the SDS-PAGE gel to the PVDF membrane; 
TBST pH 7.6 for the preparation of antibody dilutions; electrode buffer for running the SDS-PAGE gel; 5% milk in 
TBST for preparation of antibody dilutions and blocking solution. 
RIPA Lysis Buffer 2X Laemmli Buffer Transfer Buffer 
10 mM Tris-Cl pH 7.5 0.125 M Tris-Cl pH 6.8 48 mM Tris-Cl 
150 mM NaCl 10% 2-mercaptoethanol 39 mM glycine 
1 mM EDTA pH 8 20% glycerol 0.0375% SDS 
1% NP-40 0.0004% bromophenol blue 20% methanol 
0.1% SDS 4% SDS  
 
TBST pH 7.6 Electrode Buffer 5% milk in TBST 
20 mM Tris-Cl 25mM Tris-HCl 1 gram fat-free powdered milk 
140 mM NaCl 192mM glycine 20 mL TBST pH 7.6 
0.1% Triton X-100 0.1% SDS  
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2.5.2: Western Blot: Preparation of Whole-Cell Lysates 
Day 0, 7.5 x 105 HT29 cells were seeded into three T75 flasks.  These NaBT treated 
HT29 cells were maintained with the supplemented media as previously stated (see 2.1.2). On 
Day 4, three T75 flasks of untreated HT29 were seeded at the same cell density of 7.5 x 105 and 
maintained with fresh media every other day (see 2.1.1).  Day 7, the untreated and NaBT treated 
cells were harvested for whole cell lysates.   
 The media was removed from the flasks and discarded; the cells were rinsed with 4°C 1X 
PBS.  The PBS was aspirated and discarded, and 1 mL RIPA lysis buffer was pipetted into each 
flask.  The contents were removed after scraping with a rubber policeman and placed into cold 
1.5 mL RNase-free microcentrifuge tubes.  2 µL of protease inhibitor cocktail was added to each 
sample.  The samples were then vortexed continuously for 20 minutes at 4°C.  The tubes were 
then centrifuged at 4°C for 5 minutes at maximum speed.  The supernatant was removed at 
stored at -80°C or used immediately for quantification by a Pierce 660 Assay.   
 The Pierce 660 Assay was performed using a 2 mg/mL standard of BSA.  The sample 
tubes were prepared as follows. (Table 5)  
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Table 5. Pierce 660 Assay sample preparations.  For the BSA standard, seven tubes are prepared using the appropriate 
volumes.  The volume of protein used for these tubes is from the 2 mg/mL BSA stock.  For the lysates, two tubes were 
prepared for each of the untreated and treated whole-cell lysates; the volume of protein used for these tubes is derived 
from the whole-cell lysate stocks. 
 
Tube Vol. Pierce Reagent (mL) Vol. H2O (µL) 
Vol. RIPA 
Buffer (µL) Vol. Protein (µL) 
BS
A
 
St
a
n
da
rd
 
1 1 80 20 0 
2 1 70 20 10 
3 1 60 20 20 
4 1 50 20 30 
5 1 40 20 40 
6 1 30 20 50 
7 1 20 20 60 
Ly
sa
te
s 
1 1 80 10 10 
2 1 80 0 20 
 
Once prepared, the samples were inverted to mix and incubated at room temperature for 5 
minutes.  The samples were then transferred to a 1 mL plastic cuvette before measuring and 
recording the absorbance (λ=660 nm).  The machine used was a Shimadzu 1201 UV-Vis 
spectrophotometer. 
 
2.5.3: Western Blot: SDS- PAGE 
 Resolving and stacking gels were first poured.  For the D8 and D9 proteins, a 10% 
resolving gel and a 4% stacking gel were adequate.  For the 10% resolving gel: 
  1.25 mL 40% acrylamide/bis-acrylamide (Biorad) 
  2.45 mL distilled H20 
  1.25 mL 1.5 M Tris-Cl pH 8.8 
  50 µL 10% SDS 
  2.5 µL TEMED 
  25 µL 10% APS 
After mixing the reagents in a 15 mL conical tube, approximately 5 mL (or to ~1 cm from the 
bottom of the comb when inserted) was pipetted into an assembled Biorad Gel Casting Tray 
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cartridge.  Carefully, 70% ethanol was dispensed atop the resolving gel in order to prevent 
interaction with environmental oxygen.  The gel polymerized at room temperature for one hour.  
The ethanol was removed and the 4% stacking gel was prepared: 
  0.25 mL 40% acrylamide/bis-acrylamide 
  1.6 mL distilled H20 
  0.625 mL 0.5 M Tris-Cl pH 6.8 
  25 µL 10% SDS 
  2.5 µL TEMED 
  12.5 µL 10% APS 
The reagents were mixed in a 15 mL conical tube and added on top of the resolving gel.  The 
comb was inserted and the gel polymerized at room temperature for approximately 45 minutes.  
The comb was removed and the gel cartridge was transferred to a Biorad Mini-PROTEAN® 
Tetra Cell Tank assembly.  The chamber was then filled with 1X electrode buffer; the wells were 
also rinsed with the electrode buffer.  
 Next, 10 µg of each respective untreated or treated cell lysate was added to an equal 
volume of 2X Laemlli loading buffer into 250 µL PCR reaction tubes.  The solution was boiled 
at 95 °C for 5 minutes and briefly centrifuged.  The gel was then loaded with 10 µL PageRuler™ 
Precision Plus pre-stained ladder (Thermoscientific) in the first lane, and the supernatant solution 
from the prepared samples of lysate/Laemelli loading buffer.  Any empty or unused lanes were 
loaded with 10 µL of 2X Laemlli loading buffer.  The SDS-PAGE gel was electrophoresed at 90 
V for 1.5 hours, or until the dye and lowest band of the ladder had traveled to the near end of the 
gel.   
 
2.5.4: Western Blot: Semi-Dry Transfer 
 After running the SDS-PAGE, the gel was removed from the cartridge, cutting the 
stacking gel from the resolving gel.  The resolving gel was the only portion kept and used for the 
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remainder of the Western blot.  The resolving gel was then rinsed in cold transfer buffer for 10 
minutes.  Additionally, 6 pieces of Whatman paper were soaked in transfer buffer for 5 minutes 
at room temperature after being cut to the appropriate size (a little larger than the size of the gel).   
Immobilon-P polyvinylidene difluoride (PVDF) membrane (Millipore) was cut to the size of the 
gel and soaked in cold 100% methanol for 1 minute.  The PVDF membrane was then transferred 
to distilled water, soaking for 2 minutes, and finally to cold transfer buffer for 5 minutes.  The 
transfer was then set up on the LKB© 2117 Multiphor II Electrophoresis Unit electrode plate.  
First, 3 of the 6 soaked Whatman paper sheets were laid down and rolled over with a glass stir 
rod to remove bubbles; a few milliliters of transfer buffer was poured over the top of the paper.  
The PVDF membrane was placed on top of the Whatman paper, followed by the SDS-PAGE 
resolving gel, ensuring that the gel only overlapped the membrane.  The gel was topped with the 
three remaining pieces of Whatman paper, a few milliliters of transfer buffer, and subsequently 
rolled again using the glass stir rod.  The extra transfer buffer was removed from the electrode 
plate using a sheet of heavy-duty filter paper.  The top of the transfer apparatus was installed and 
the electrodes connected to a power source.  The gel was transferred for 40 minutes at 200 
mAmps.  Following the transfer, the apparatus was opened, and the gel and filter paper were 
discarded.  The membrane was kept for the remainder of the Western blot. 
 
2.5.5: Western Blot: Blocking and Antibodies 
 From the transfer, the membrane was blocked with 5% milk in TBST buffer for 1 hour at 
room temperature on a shaker table.  The membrane was then washed 5 times for 5 minutes, 
each at room temperature.  After washing, the membrane was incubated in the primary antibody: 
mouse monoclonal IgG purified D8 or D9 (Novus Biologicals 10F8, 2A9) prepared at a 1:500 
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dilution with the 5% milk in TBST buffer for 4 hours at room temperature or up to overnight at 
4°C.  The primary antibody incubations were performed using a shaker table to ensure the 
solution covered the entirety of the membrane.  The primary antibody solution was then 
discarded and a secondary antibody solution was added: a 1:5000 mouse horseradish peroxidase-
conjugated antibody with the 5% milk in TBST for 1 hour at room temperature on a shaker table.  
The membrane was then ready for chemiluminescence (see 2.5.6).  
After chemiluminescence and imaging, the membrane was prepared for incubation with 
the loading control antibody.  The membrane was stripped for 5 minutes at room temperature 
using a mild stripping buffer.  Following the stripping wash, two washes for 10 minutes each in 
cold 1X PBS and two 5-minute washes in cold 1X TBST were performed.  The PVDF 
membrane was then blocked following the same steps and incubated with a β-Actin primary 
antibody at a 1:5000 dilution with the 5% milk in TBST solution.  The membrane was washed 
following the same steps and incubated with the mouse secondary antibody at a 1:5000 with the 
5% milk in TBST solution.  The membrane was again ready for chemiluminescence. 
 
2.5.6: Western Blot: Chemiluminescence and Imaging 
In order to visualize the presence of the targeted proteins, the Immobilon Western 
Chemiluminescent HRP Substrate Kit was used.  The membranes were incubated in equal 
volumes of HRP substrate luminol reagent and HRP substrate peroxidase solution for 5 minutes 
at room temperature, with constant motion.  The membranes were imaged using the BioRad 
ChemiDoc XRS+ System.  
 Chapter 3: Results and Discussion 
 
3.1: Hox Gene Pattern of Expression and the Effects of Sodium Butyrate on Cell Growth 
 The first objective in this research was to determine the overall pattern of expression of 
Hox genes in the cell line HT29.  This was done by performing RT-PCR on cDNA prepared 
from both untreated and sodium butyrate treated HT29 cells.  cDNA from three different sets of 
both untreated and treated HT29 cells was used to perform replicates for each of the 39 genes 
tested.  Once RT-PCR was performed, the samples were electrophoresed on a 1.5% agarose gel 
and the presence or absence of a band at the proper amplicon size was used to determine if the 
gene was expressed.  For each set of cDNA tested, positive and negative controls using β-actin 
primers were used.  The negative control did not contain any cDNA template. 
 The presence, ‘+’, or absence, ‘-‘, of an amplicon band at the appropriate size for each 
Hox gene is compiled in the chart below.  (Table 6) 
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Table 6. Hox gene pattern of expression in both untreated and NaBT treated HT29 cells.  (+) indicates expression, (-) 
indicates no expression. 
Gene Untreated HT29 Expression 
Treated HT29 
Expression Gene 
Untreated HT29 
Expression 
Treated HT29 
Expression 
A1 + -    
A2 + + B13 - + 
A3 + + C4 - - 
A4 + + C5 + + 
A5 + + C6 + + 
A6 + + C8 + + 
A7 + + C9 + + 
A9 + + C10 + + 
A10 + + C11 + + 
A11 + + C12 + + 
A13 + + C13 + + 
B1 - - D1 + + 
B2 + - D3 + - 
B3 + + D4 + - 
B4 + + D8 + - 
B5 - + D9 + - 
B6 + + D10 + - 
B7 + + D11 + - 
B8 + + D12 - - 
B9 + + D13 + + 
 
 After analyzing the qualitative pattern of expression, the goal was to select a couple of 
genes of interest.  The genes selected must show a differential pattern of expression in the 
untreated or treated HT29 cells.  Many of the genes of cluster D were expressed in untreated 
HT29, but not in sodium butyrate treated HT29.  
 In addition to analysis of the RT-PCR results, a cell growth curve was performed in order 
to determine the effects of sodium butyrate on cellular growth and proliferation.  If sodium 
butyrate is effectively differentiating the HT29 cells, it would be expected that untreated cells 
continue to exponentially proliferate and the treated cells would not.  The cells were seeded at a 
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density of 9.6 x 104 cells/35 mm petri dish, as per the 10,000 cells/cm2 guidelines adapted from 
Augeron et. al, 1984. The growth curve indicated that untreated HT29 cells began to proliferate 
on day 5, toward the end of growth curve period.  However, growth in NaBT treated HT29 cells 
seemed to plateau in growth between days 2 and 3 of the seven-day treatment, and no longer 
proliferate (Figure 5). 
 The decrease in cell number between days 2 and 3 for both untreated and treated HT29 
cells could be attributed to human error (pipetting of suspended cells on day 0, when all of the 
petri dishes were seeded).  Also, the suggested cell density at which the untreated and treated 
cells were seeded is lower than optimal for normal growth. 
 The conclusions from the results of this graph show that untreated HT29 continue to 
proliferate, while sodium butyrate treated HT29 plateau and do not proliferate throughout the 
course of the treatment.  This suggests that sodium butyrate prevents the proliferation of HT29 
cells. 
 
Figure 5.  HT29 cell growth curve showing the effects of 5 mM sodium butyrate treatment over the seven-day treatment 
period.  The cells were seeded into 35 mm petri dishes at a density of 9.6 x104 cells on day 0.  Three petri dishes of each 
untreated and treated HT29 cells were harvested and counted for each day of the growth curve. 
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 As stated in the literature, specific genes from paralog groups 8 and 9 are expressed 
during various stages of colorectal cancer. [Vider 1997]  Additionally, Hox gene expression in 
cells that maintain the undifferentiated state are located at the base of the colonic epithelial 
crypts, where proliferation of stem cells occurs.  [Freschi 2005]  The preliminary results 
indicated that Hox genes D8 and D9 are expressed only in untreated HT29 cells and not in 
sodium butyrate treated HT29 cells, by RT-PCR.  In correlation with the cell growth curve, the 
untreated HT29 cells continue to proliferate whereas treated HT29 cells do not.  Thus, it was 
hypothesized that Hox genes D8 and D9 may be responsible for maintaining the proliferative 
state of untreated HT29 cells.  Therefore, D8 and D9 were targeted for further investigation. 
 
3.2.: Hox D8 and D9 Expression 
 The second objective was to determine the level of expression of D8 and D9 by use of 
quantitative Real-time PCR.  These genes of interest were normalized to seven housekeeping 
genes and compared to determine the effectiveness of the Pfaffl method of calculation for the 
reactions.  If the non-quantitative RT-PCR detection was an accurate representation of gene 
expression, the level of expression of D8 and D9 would be up-regulated in untreated HT29 cells 
and down-regulated or not expressed in NaBT treated HT29 cells. 
 The Pfaffl calculations (Appendix B) yielded a ratio of expression for sodium butyrate 
treated to untreated cells.  Therefore, for each gene plot, the columns indicate the normalized 
level of expression of each gene of interest to the reference gene.  In each dilution, an additional 
column “untreated D8” or “untreated D9” represents the normalized value of 1 for the untreated 
samples. (Figures 6-7)  For comparison, two housekeeping genes were selected for each gene of 
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interest; one housekeeping gene with a CT value close to that of the GOI, and the other with a CT 
value differing from that of the GOI.  The genes of interest were then normalized to these 
selected reference genes and analyzed.  In Figure 6, Hox D8 is normalized to β-Actin and TATA 
binding protein.  ACTB has a higher level of expression in the starting quantity of 0.25 than in 
the other two dilutions: 2.4 as compared to 0.7.  Additionally, TBP also has a higher level of 
expression at the template starting quantity of 0.25 than in the other dilutions: 1.0 as compared to 
0.5. (Appendix B)  This trend was observed for D8 normalization to all of the remaining 
housekeeping genes. (Appendix C)  At the 0.05 dilution, a down-regulation of Hox D8 in sodium 
butyrate treated HT29 cells was observed, independently of the gene used for normalization. 
However, down-regulation folds differ depending on the reference gene and are higher when 
using the TBP gene that has a closer value to that of Hox D8.    
Figure 6. (below)  NaBT treated and untreated D8 expression after normalization to β-actin, ACTB, and TATA binding 
protein, TBP.  
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Figure 7. (below) NaBT treated and untreated D9 expression after normalization to β-actin, ACTB, and ribosomal protein 
L13a, RPL13a.  
 
 
In Figure 7, D9 expression is normalized to ACTB and RPL13a.  Because the CT value 
for D9 was so much later than any of the others, both of the housekeeping genes differ in CT.  It 
can be determined from this figure that D9 has more variation within the samples for both treated 
ACTB and RPL13a.  In addition, the level of expression indicates that in more dilute templates, 
there is a higher level of expression.  Interestingly, the results showed an up-regulation of Hox 
D9, which contradict the observations from RT-PCR.  The values for D9 can be accounted for by 
one of the following: 1) error propagation by incorrect efficiency calculations or 2) low detection 
and CT values due to low levels of expression in the cells.    
 Overall, in Hox D8, the untreated HT29 had a higher level of expression than the 5 mM 
sodium butyrate treated HT29.  Hox D9 had a higher level of expression in the treated HT29 
versus the untreated HT29. (Appendix C) 
 
 
0
20
40
60
80
100
120
140
0.25 0.05 0.01
N
o
rm
a
liz
ed
 
Ex
pr
es
io
n
 
Le
v
el
cDNA Concentration 
D9 Expression after ACTB and RPL13a 
Normalization
D9/ACTB
D9/RPL13a
Untreated D9
 43 
3.3: Hox D8 and D9 Protein Expression 
The third objective was to determine protein presence in the untreated and treated HT29 
samples by use of Western blot and antibodies specific to Hox D8 and D9.  If the Western blot 
validated the RT-PCR results, then expression of proteins D8 and D9 would be expected in 
untreated but not in NaBT treated HT29 cell lysates. 
For both Western blots, three different sets of each untreated and treated cell lysates were 
used.  The lanes were loaded as follows: 1- untreated 1, 2- treated 1, 3- untreated 2, and 4- 
treated 2.  The loading control used was β-Actin, which is located at the bottom of the images.  
(Figure 8) 
 
Figure 8. (above) Images of Western blot PVDF membranes for both Hox D8 (left) and D9 (right). Lanes for both 
correspond to the following: 1) Untreated Cell Lysate 1, 2) NaBT Treated Cell Lysate 1, 3) Untreated Cell Lysate 2, 4) 
NaBT Treated Cell Lysate 2.  The size of the proteins: D8- 36.1 kDa, D9- 37 kDa, β-actin- 37 kDa.  10 µg of protein was 
loaded into each lane.  
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 The size of the protein for Hox D8 was 36.1 kDa. (Novus Biologicals)  The Western blot 
for this protein yielded no results as it either did not work under the conditions used, or there is 
no protein expression of Hox D8 in either untreated or treated HT29.   
 The size of the protein for Hox D9 was 37 kDa with a secondary unidentified protein 
located between 55 and 75 kDa.  The protein was found to be expressed or present in untreated 
HT29 but not in the sodium butyrate treated HT29.  
 
3.3: Ultrastructural Features of HT29 cells: Untreated and Sodium Butyrate Treated 
In order to determine if sodium butyrate treatment had an effect on the phenotype of the 
treated cells when compared to untreated HT29 cells, the ultrastructure of both untreated and 
treated cells were studied with transmission electron microscopy.  If sodium butyrate induced 
differentiation, the number of tight junctions and microvilli density should both increase as 
compared to the untreated HT29 cells.  However, because HT29 in their “normal” or untreated 
state possess microvilli, tight junctions were iden
  
Figure 9. Micrographs of cellular junctions
protrusion.  B- (6.3 x 103 magnification) 
conformation potentially due to nonpolar, multi
cells with a heavy concentration of microvilli in betw
between two cells, containing vacuoles and vesicul
Euchromatin, H: Heterochromatin, MV: Microvilli, V: Vacuoles, VV: Vacuoles containing vesicles.)
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 in untreated HT29.  A- (100.0 x 103 magnification) A desmosome and a bleb 
Junctions at the convergence of three cells; the bottom left cell is in a different 
-layer growth.  C- (13.0 x 103 magnification) The junction between two 
een.   D- (45.0 x 103 magnification) A micrograph of a junction 
ar vacuoles, as well as a desmosome.  (B: Bleb, D: Desmosome, E: 
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Figure 10. Micrographs of 5 mM NaBT treated HT29 cells. A- (53.0 x 103 magnification) A desmosome with its adjoining 
microfilaments and microvilli.  B- (40.0 x 103 magnification) Tight junctions at the convergence of two cells, with some 
microvilli between the two cells .  C- (11.5 x 103 magnification) A tight junction between two cells, with a mitochondria 
with well-defined cristae.  D- (7.1 x 103 magnification) A micrograph of tight junctions between two cells, containing two 
nucleoli within the nucleus.  (D: Desmosome, MV: Microvilli, N: Nucleus, Nu: Nucleolus.) 
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In both the untreated and treated HT29 cells, there was a high concentration of microvilli. 
(Appendix D)  However, in terms of tight junctions between the cells, the number was much 
higher in 5 mM NaBT treated cells.  In order to quantify this difference, the number of tight 
junctions at cellular interfaces was counted for each untreated and treated HT29 cell.  For 
example, if there were two cells with a tight junction between them, a value of 1 was given for 
the tight junctions and a value of 2 was given to the cell number.  In addition, there were 
desmosomes in both samples; they were quantified the same way as the cell number.  As seen 
below in Table 7, the number of desmosomes and tight junctions increased in the treated HT29 
cells in comparison with those of the untreated HT29. 
   
Table 7. Quantification of the effects of sodium butyrate treatment on HT29 and the development of tight junctions and 
desmosomes.  The number of desmosomes and tight junctions in both untreated and NaBT treated HT29 cells were 
counted for all of the cells imaged.  The number represents the number of identifiable structures out of a total number or 
“cell count”. 
 Desmosomes Tight Junctions 
Number Number Cell Count 
Untreated HT29 3 0 19 
Sodium Butyrate Treated HT29 7 13 29 
 
Tight junctions and desmosomes were identified as darkened or electron dense structures 
within the cells.  Tight junctions are narrow and appear as a very defined membranous, “tube”-
like structure at the interface between cells.  Desmosomes have attached microfilaments that 
were seen going through the cell to the cellular interface and continuing on the other side.  These 
structures are used for cellular adhesion.   
The intracellular structures, cellular junctions, extracellular structures and general 
features of the cells were also studied. The cells range in size and shape dependent upon growth 
 48 
conformation (i.e. multi-layered or monolayer) and orientation in the sections; however, the 
average cell size was approximately 8.5 µm in diameter.  These cells have a high number of 
intracellular vacuoles, with some vacuoles containing vesicles. The vacuoles range in size from 
0.50µm- 2.02µm in diameter.  The vacuoles containing vesicles are somewhat intermediately 
sized around 1 µm in diameter.  The HT29 cells show a nucleolus and a large amount of both 
heterochromatin and euchromatin (Figures 9-11, Appendix D)  On average, the nucleoli had a 
diameter of 1.8 µm at the widest point.  The size of the nucleus, at the widest point in diameter 
from membrane-membrane) is 4.8 µm on average.  The cells also have microvilli projections 
from the membrane.  The microvilli sizes range from 0.40 µm being the smallest, and 0.99 µm 
being the largest.  Smaller projections, anything between 0.1-0.3 µm protrusions from the 
membrane are classified as blebs.  These protrusions are extensions of the plasma membrane and 
are not considered members of the microvilli family. 
 In addition to the desmosomes, tight junctions and general features of the cells, there 
appeared to have been the formation of some type of apical domain in some of the cell sections 
of the sodium butyrate treated HT29. (Figure 11) 
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Figure 11.  (11.5 x 103 magnification) 5 mM NaBT treated HT29 cells.  In this micrograph, there 
appeared to be the formation of an apical (api*) domain at the top of the micrograph.  The cells 
converged, possessing tight junctions (TJ) and microvilli (MV).  
 Chapter 4: Conclusions 
 In conclusion, the pattern of expression of Hox genes in untreated and treated HT29 cells 
led to suggest that D8 and D9 are responsible for maintaining the proliferative and 
undifferentiated state of the HT29 cells.  This also suggests that sodium butyrate is inducing 
differentiation in this cell line.  The findings provide some support to the original hypothesis that 
Hox genes expressed only in proliferating HT29 cells are responsible for maintaining the 
proliferative and undifferentiated state of these cells; however, the results remain too 
inconclusive to either accept or reject the hypothesis. 
 
 The targeted genes of interest, Hox D8 and D9, left some open-ended questions.  The 
qRT-PCR results seemingly confirmed the observation of the RT-PCR experiments for gene D8.  
There was an increased level of expression in untreated cells, with a lower level of expression in 
the treated HT29 cells.  However, there were some discrepancies with the resulting data for gene 
D9.  There appeared to be a higher level of expression in treated than in untreated cells.  This 
was not in agreement with the RT-PCR data where both genes were expected to have an up-
regulated or higher level of expression in untreated versus treated.  After reviewing the literature, 
there are some issues with the use of qRT-PCR to determine relative levels of gene expression.  
The problems arise with the interpretation of the results.  Ideally, a target gene will be 
normalized to a stable internal control, or a reference gene that does not fluctuate in expression.  
When normalizing data against a housekeeping gene(s), variations can occur.  For example, 
among different types of tissue, housekeeping genes can fluctuate in their level of expression.  
Additionally, if a treatment is used on cells in culture, the housekeeping gene expression can 
again be affected. [Vandesompele 2002]  It is known that sodium butyrate has an effect on the 
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metabolism of cells, as well as other enzymes such as alkaline phosphatase. [Candido 1978]  The 
housekeeping genes selected for this research have been used in other papers as reference genes 
for qRT-PCR; however, it is unknown if sodium butyrate treatment has any effect on their levels 
of expression.  If these reference gene expression levels are being altered by treatment, using 
them as an internal control in these experiments could have propagated error in the data, as they 
are not truly stable. 
 The reference genes are not the only possible source of error in the resultant data for 
qRT-PCR.  After treatment for seven days with sodium butyrate, it is assumed that all of the cells 
in culture have responded in the same way to the presence of the chemical. If sodium butyrate 
induces differentiation of HT29 cells, all of the cells present are differentiated, for example.  It is 
known that the effects of sodium butyrate can be reversed if the chemical is no longer present in 
the culture media.  Therefore, if the sodium butyrate was metabolized in vitro or was not at the 
appropriate concentration, the cells could begin to revert to an undifferentiated state. [Candido 
1978]   
 Lastly, the error in D9 could be resultant of the gene being expressed at low level within 
the harvested cells.  If the level of expression was beyond the sensitivity of detection in the 
reactions, the calculated values could in fact be erroneous.   
 In future research, a program such as geNorm (now part of the qBase+ software) should 
be used, in which the geometric mean of the output data for a battery of reference genes is 
normalized and the most stable of these genes is selected as the internal control for the genes of 
interest.  Additionally, selecting reference genes that are not affected by sodium butyrate would 
be ideal.  It could also be beneficial to design new sets of primers for the genes of interest.  In 
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conclusion, because D8 seemed to confirm previous data and D9 did not, the results of qRT-PCR 
for these experiments may be unreliable data.  
 
In analyzing the protein expression of Hox D8 and D9 by use of Western blot, it was 
observed that D9 was expressed only in untreated HT29 cell lysates.  This confirmed the 
preliminary RT-PCR results.  D8 did not have any protein expression in either untreated or 
treated cell lysates, which was unexpected from both RT- and qRT-PCR results.  There are a few 
possible explanations for this occurring.  First, it is possible that the conditions for the antibody 
although suggested by the company, were not optimal for the detection of protein.  Or second, 
because there was expression of the gene in both RT- and qRT-PCR, mRNA is present in these 
cells but not being translated.   
Additionally, there was a problem with the transfer, in which the lanes on the outermost 
side of the membranes did not transfer as well as the other lanes.  This led to a less distinctive 
band in both the gene of interest (D9) and the β-actin loading control in lanes 5 and 6.  The 
results in these lanes were in agreement with lanes 1-4.  However, because of the slight decrease 
in intensity of the bands in the treated β-actin loading control versus the untreated controls; it 
brings into question whether the results of the Western are specific to the levels of D9 expression 
or are just an artifact of lower protein concentration in the samples.   
 
Cell growth curves and transmission electron microscopy results suggest that sodium 
butyrate treatment is differentiating the cells.  The ultrastructural phenotypes observed, such as 
the increase in tight junctions, desmosomes, potential apical domain and mucin granule 
formation; suggest that the cells begin to exhibit features of differentiated colonic epithelial cells.  
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This is reflected in the results of the cellular growth curve in which untreated HT29 cells are 
seen to exponentially proliferate while treated HT29 cells do not seem to grow.   
These results are consistent with the literature.  It has been observed that sodium butyrate 
acts to regulate cellular growth in many types of cells, most of which in a dose-dependent 
manner. [Van Wijk 1981]   More specifically, research indicates that sodium butyrate inhibits 
proliferation and growth of HT29 cells in vitro. [Barnard 1993]  The research conducted in 
sodium butyrate treated HT29 conclude that treatment inhibits cellular proliferation by inducing 
a block of cells at the G0/G1 phase of the cell cycle. [Barnard 1993, Coradini 2000]  In one 
particular study of interest, cells were treated with sodium butyrate for three days at varying 
concentrations.  The researchers observed 75% growth inhibition at a concentration of 4 mM 
sodium butyrate.  They also noticed an increase in the percentage of cells with inhibited growth; 
a higher number of G0/G1 arrested cells, after an extended treatment period of 6 days. [Coradini 
2000]   The more recent studies indicate that at a higher concentration (4 mM and higher), cells 
first differentiate and eventually trigger apoptosis. [Barnard 1993, Coradini 2000]  This cell 
cycle arrest is accompanied by metabolic changes in the cells, as well as histone deacetylase 
inhibitory activity. [Alcarraz-Vizián 2010] 
In reviewing the literature to look for associations of the two genes of interest Hox D8 
and D9 with proliferation of cells, it was recently reported that Hox genes of cluster D were 
expressed in neoplastic astrocytes and low-grade gliomas. [Abdel-Fattah 2006, Buccoliero 2009]  
Astrocytes are a type of glial cell, localized in the central nervous system.  Gliomas are tumors of 
the brain and/or spinal cord.  A low-grade glioma refers to the level of differentiation, much like 
in the colorectal adenocarcinoma cell line of study, which is moderately differentiated.  This 
research led to further studies in which D9 expression was increased in stem cell-like gliomal 
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cells.  Additionally, silencing the gene yielded apoptotic induction and lower expression of a 
cell-death regulating protein, Bcl-2.  The researchers concluded that Hox D9 may promote 
survival of the cells and proliferation. [Tabuse 2011]  Furthermore, D9 was also linked to a 
potential role in synoviocyte proliferation.  Synoviocytes are fibroblast-like cells found in the 
synovial join of an organism.  In this particular study, the cells were derived from patients with 
rheumatoid and osteo-arthritis. [Khoa 2001] 
 
Because of the interest in the use of histone deacetylase inhibitors on tumorous metabolic 
pathways, and combined gene and drug therapies, future research could have vast implications.  
Any insight into the roles of specific genes and treatments on these cells in culture shed light on 
possible genes of interest to target for one of the leading causes of cancer-related death in the 
United States and western countries. [Alcarraz-Vizán 2010, CDC 2012, Coradini 2000]  Future 
research could include further investigation of Hox genes D8 and D9, and the established 
objectives of this project.  This includes analysis with a different type of software for qRT-PCR; 
with housekeeping genes that are identified as stable in both untreated and sodium butyrate 
treated HT29 cells.  Additionally, conditions for Hox D8 Western blot could be optimized, or 
another antibody selected to verify the results of this research.   
To ensure that the cells are effectively differentiated upon treatment with 5 mM sodium 
butyrate for seven days in culture, a dose-dependent cell growth curve and FACS analysis could 
be used.  The dose-dependent response curve would indicate if cell proliferation inhibition was 
optimized at a 5 mM concentration. Flow cytometry or FACS analysis could be used to indicate 
if the results of the cell growth curve are due to the arrest of cells at the G0/G1 phase, as found in 
the literature.   
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To determine if the Hox genes D8 and D9 are responsible for maintaining the 
proliferative state of these cells, these genes could be targeted for silencing.  Cell growth curves, 
FACS analysis, and q/RT-PCR detection of genes expressed only in a proliferating cell could be 
performed to determine if silencing inhibits cellular growth and proliferation.  Additionally, 
other genes of the same paralogs could be tested for relative levels of expression upon silencing 
of the genes of interest.  Recent research has also indicated that adjacent genes on the same 
cluster are more likely to have similar expression patterns than those located on different 
chromosomes. [Takahashi 2004]  Therefore, genes in cluster D that also showed the differential 
pattern of expression could be targeted for further investigation. 
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Table 8. qRT-PCR data for each of the (7) housekeeping genes and (2) genes of interest.  The cDNA dilution corresponds 
to the starting amount of template used for each reaction.  The average CT values were taken from all three trials and 
respective replicates.  The efficiency calculated here is the average efficiency in both untreated and treated.  These 
numbers were used for Pfaffl analysis of data. 
 
Gene cDNA Dilution 
Untreated 
Average CT 
Treated 
Average CT Average Efficiency 
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ACTB 0.25 19.58 20.75 
110.50% 0.05 21.47 22.44 
0.01 24.08 24.89 
B2M 0.25 24.66 24.67 
155.50% 0.05 25.94 26.19 
0.01 28.16 28.09 
GAPDH 0.25 22.14 23.41 
154.20% 0.05 23.55 24.84 
0.01 25.64 26.80 
RPL13a 0.25 18.98 19.28 
115.40% 0.05 20.83 21.12 
0.01 23.17 23.48 
RPLPO 0.25 21.78 22.92 
139.70% 0.05 23.48 24.30 
0.01 25.49 26.54 
TBP 0.25 24.45 23.77 
111.20% 0.05 26.48 25.63 
0.01 28.87 28.17 
TFRC 0.25 24.80 24.46 
105.80% 0.05 26.81 26.31 
0.01 29.36 28.82 
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D8 0.25 25.27 25.28 
121.95% 0.05 25.90 27.06 
0.01 27.66 28.90 
D9 0.25 33.80 32.28 
188.26% 0.05 37.44 34.33 
0.01 38.53 34.56 
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Figure 12.  qRT-PCR raw data depicting relative fluorescence units (RFU) versus CT for genes of interest D8 and D9.  (A) Amplification curve for D8 in untreated HT29 
cells.  (B) Amplification curve for D8 in 5 mM sodium butyrate treated HT29 cells.  (C) Amplification curve for D9 in untreated HT29 cells.  (D) Amplification curve for 
D9 in 5 mM sodium butyrate treated HT29 cells. 
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Figure 13. qRT-PCR raw data depicting relative fluorescence units (RFU) versus CT for housekeeping genes ACTB, B2M, GAPDH and RPLPO.  (A) Amplification 
curve for ACTB in both untreated and treated HT29 cells.  (B) Amplification curve for B2M in both untreated and treated HT29 cells.  (C) Amplification curve for 
GAPDH in both untreated and treated HT29 cells.  (D) Amplification curve for RPLPO in both untreated and treated HT29 cells. 
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Figure 14. qRT-PCR raw data depicting relative fluorescence units (RFU) versus CT for housekeeping genes RPL13a, TBP and TFRC.  (A) Amplification curve for 
RPL13a in both untreated and treated HT29 cells.  (B) Amplification curve for TBP in both untreated and treated HT29 cells.  (C) Amplification curve for TFRC in 
both untreated and treated HT29 cells.   
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Figure 15. (above) Relative levels of expression of untreated and treated Hox D8 when normalized to each of the (7) 
housekeeping genes.  A noticeable variation in the level of expression of D8 normalized to the housekeeping genes at a 
dilution of 0.25.  However, the trend of a decreased level of expression of treated D8 compared to untreated D8 expression 
was observed for the other two dilutions.    
Figure 16. (below) Relative levels of expression of untreated and treated Hox D9 when normalized to each of the (7) 
housekeeping genes.  The trend of increased level of expression of housekeeping normalized treated D9 expression in 
comparison to untreated D9 was observed for all dilutions of the cDNA template. 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
0.25 0.05 0.01
N
o
rm
a
liz
ed
 
Ex
pr
es
io
n
 
Le
v
el
cDNA Concentration 
D8 Expression Levels after Housekeeping 
Normalization
D8/ACTB
D8/B2M
D8/GAPDH
D8/RPL13a
D8/RPLPO
D8/TBP
D8/TFRC
Untreated D8
0
20
40
60
80
100
120
140
160
180
200
0.25 0.05 0.01
N
o
rm
a
liz
ed
 
Ex
pr
es
io
n
 
Le
v
el
cDNA Concentration 
D9 Expression Levels after Housekeeping 
Normalization
D9/ACTB
D9/B2M
D9/GAPDH
D9/RPL13a
D9/RPLPO
D9/TBP
D9/TFRC
Untreated D9
 Figure 17. (above) Relative levels of expression of untreated and treated 
β-actin, ACTB.  Treated D8 expression, normalized to ACTB, for each concentration of template was as follows 
(concentration = level of expression): 0.25 = 2.
all concentrations.   
Figure 18. (below) Relative levels of expression of untreated and treated 
β-2 microglobulin, B2M. Treated D8 expression, normalized to B2M, for each concentration of template was as follows 
(concentration = level of expression): 0.25 = 1.0, 0.05 = 0.5, and 0.01 = 0.5.  The normalized value for untreated D8 = 1 at 
all concentrations.   
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Hox D8 when normalized to
4, 0.05 = 0.7, and 0.01 = 0.7.  The normalized value for untreated D8 = 1 at 
Hox D8 when normalized to 
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 Figure 19. (above) Relative levels of expression of untreated and treated 
glyceradldehyde 3-phospate dehydrogenase, GAPDH.
concentration of template was as follows (concentration = level of expression): 0.25 = 3.2, 0.05 = 1.3, and 0.01 = 1.1.  The 
normalized value for untreated D8 = 1 at all concentrations.  
Figure 20. (below) Relative levels of expression of u
human acidic ribosomal protein 0, RPLPO.
template was as follows (concentration = level of expression): 0.25 = 2.7, 0.05 
for untreated D8 = 1 at all concentrations.  
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  Treated D8 expression, normalized to GAPDH, for each 
 
ntreated and treated Hox D8 when normalized to housekeeping gene 
 Treated D8 expression, normalized to RPLPO, for each concentration of 
= 0.9, and 0.01 = 0.9.  The normalized value 
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 Figure 21. (above) Relative levels of expression of untreated and treated 
ribosomal protein L13a, RPL13a. Treated D8 expression, normalized to RPL13a, for each concentration of template was 
as follows (concentration = level of expression): 0.25 = 1.3, 0.05 = 0.5, and 0.01 = 0.5.  The norm
D8 = 1 at all concentrations.   
Figure 22. (below) Relative levels of expression of untreated and treated 
TATA binding protein, TBP. Treated D8 expression, norm
follows (concentration = level of expression): 0.25 = 0.6, 0.05 = 0.2, and 0.01 = 0.2.  The normalized value for untreated D8
= 1 at all concentrations.   
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 Figure 23. (above) Relative levels of expression of untreated and treated 
transferrin receptor C, TFRC. Treated D8 expression, normalized to TFRC, for each concentration of template was as 
follows (concentration = level of expression): 0.25 = 
= 1 at all concentrations.   
Figure 24. (below) Relative levels of expression of untreated and treated 
β-Actin, ACTB. Treated D8 expression, normalized to 
(concentration = level of expression): 0.25 = 
1 at all concentrations.   
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 Figure 25. (above) Relative levels of expression of untreated and treated 
β-2 microglobulin, B2M.  Treated D8 expression, normalized to B2M, for each concentration of template was as follows 
(concentration = level of expression): 0.25 = 5.0, 0.05 = 34.0, and 0.01 = 62.6.  The normalized value for untreated D8 = 1 
at all concentrations.   
Figure 26. (below) Relative levels of expression of untreated and treated 
glyceraldehyde 3-phospate dehydrogenase, GAPDH.
concentration of template was as follows (concentration = level of expression): 0.25 = 14.1, 0.05 = 89.7, and 0.01 = 197.4.  
The normalized value for untreated D8 = 1 at all concentrations.  
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Hox D9 when normalized to housekeeping gene 
 Treated D8 expression, normalized to GAPDH, for each 
 
0.05 0.01
cDNA Concentration 
D9/B2M
Untreated D9
0.05 0.01
cDNA Concentration 
D9/GAPDH
Untreated D9
 
 
 Figure 27. (above) Relative levels of expression of untreated and treated 
human acidic ribosomal protein 0, RPL
template was as follows (concentration = level
value for untreated D8 = 1 at all concentrations.  
Figure 28. (below) Relative levels of expression of untreated and treated 
ribosomal protein L13a, RPL13a. Treated D8 expression, normalized to RPL13a, for each concentration of template was 
as follows (concentration = level of expression): 0.25 = 6.3, 0.05 = 33.4, and 0.01 = 84.4.  The normalized value for 
untreated D8 = 1 at all concentrations.   
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 of expression): 0.25 = 13.5, 0.05 = 55.1, and 0.01 = 167.5.  The normalized 
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 Figure 29. Relative levels of expression of untreated and treated 
binding protein, TBP. Treated D8 expression, normalized to TBP, for each concentration of template was as follows 
(concentration = level of expression): 0.25 = 3.0, 0.05 = 14.3, and 0.01 = 39.6.  The normalized value for untreated D8 = 1 
at all concentrations.   
Figure 30. Relative levels of expression of untreated and treated 
transferrin receptor C, TFRC. Treated D8 expression, normalized to TFRC, for each concentration of template was as 
follows (concentration = level of expression): 0.25 = 3.9, 0.05 = 18.8, and 0.01 = 45.3.  The normalized value for untreated 
D8 = 1 at all concentrations.   
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Figure 31. Transmission electron micrographs analyzing at the general features of 
magnification) HT29 cell undergoing lysis.  B
near a junction with another.  D- (5.0 x 
with high concentrations of microvilli.  The shape amongst these cells is attributed to nonpolar, multi
Euchromatin, H: Heterochromatin, MV: Microvilli, Nu: Nucleolus, V: Vacuole)
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untreated HT29 cells.  A
- (6.3 x 103 magnification) entire HT29 cell.  C- (8.0 x 10
103 magnification) convergence of 5 HT29 cells and the junctions between them, 
 
 
- (10.0 x 103 
3 magnification) cell 
-layer growth.  (E: 
  
Figure 32. Micrographs of various intracellular structures and organelles within untreated HT29 cells.  A
magnification micrograph of a cell confor
vacuoles both with and without vesicles, and heterochromatin.  C
to be a mitochondria near the outside of the cell.  D
euchromatin.  E- 28.0 x 103 magnification micrograph of a nucleolus and membrane bound organelle
magnification micrograph of a structure similar to that in (A).
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mation with microvilli.  B- 17.0 x 103 magnification micrograph of intracellular 
- 28.0 x 103 magnification micrograph of what appears 
- 10.0 x 103 of a cell, nucleolus, vacuoles, heterochromatin and 
 
 
- 45.0 x 103 
.  F- 17.0 x 103 
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Figure 33. Micrographs of microvilli in 5 mM NaBT treated HT29 cells. A- 31.0 x 103 magnification. B- 15.0 x 103 
magnification. 
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Figure 34. 5 mM NaBT treated HT29 micrographs. A- 29.9 x 103 magnification micrograph of a cell with four 
desmosomes at the cell-to-cell interface. Also some microvilli present between the two cells, as well as a well defined 
nucleus in the top left corner.  B- 53.1 x 103 magnification micrograph of a desmosome and corresponding microfilaments.  
C- 25.7 x 103 magnification micrograph of what appears to be mucin granules near the nucleus.  Dependent upon the 
orientation of the cell, this structure could also be part of the Golgi complex or vacuoles.  D- 55.5 x 103 of a cell, 
mitochondria, desmosome, microfilaments and intracellular microvilli. (D: Desmosome, M: Mitochondria, MF: 
Microfilaments, MV: Microvilli, MG*: Mucin granules?, N: Nucleus) 
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